Related Experiment Videos

[Surgical treatment of non-ST-elevation acute coronary syndrome]

Azmi Ozler1

  • 1Clinic of Cardiovascular Surgery, Dr. Siyami Ersek Thorax and Cardiovascular Education and Research Hospital, Istanbul, Turkey. azmiozler@gmail.com.

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|April 15, 2006
PubMed

Insights

Risk stratification is crucial for patients with non-ST elevation acute coronary syndromes to guide prognosis and early treatment. High-risk individuals benefit from early invasive strategies like coronary angiography and revascularization surgery.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Context:

  • Non-ST elevation acute coronary syndromes (NSTE-ACS) require risk stratification for optimal management.
  • Early risk assessment guides therapeutic decisions, impacting patient prognosis.
  • Current guidelines recommend an early invasive approach for high-risk NSTE-ACS patients.

Purpose:

  • To outline the importance of risk classification in NSTE-ACS.
  • To detail the recommended early invasive strategies for high-risk patients.
  • To discuss considerations for choosing revascularization techniques.

Summary:

  • Patients with NSTE-ACS should be risk-stratified to determine prognosis and guide early treatment.
  • High-risk NSTE-ACS patients are candidates for early invasive strategies, including coronary angiography and revascularization via percutaneous coronary intervention/stenting or coronary artery bypass graft (CABG) surgery.
  • Both off-pump and conventional CABG are viable surgical options, prioritizing myocardial protection and complete revascularization. Factors like patient comorbidities, anatomy, and surgical expertise influence technique selection.

Impact:

  • Facilitates personalized treatment strategies for NSTE-ACS patients.
  • Improves outcomes by guiding timely and appropriate interventions.
  • Provides a framework for decision-making in complex cardiac cases.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...